Vipul Keshavji Bhanderi, MD
NPI 1154532885ActiveIndividual· Internal Medicine, Hematology & Oncology· Columbia, MO
Internal Medicine, Hematology & Oncology (MD) in Columbia, Missouri, licensed in MO, LA and TN, with an NPI issued in May 2007. Their prescriptions cost Medicare Part D more than their services did: $493,499 for 189 claims, against $38,497 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2025, $8,506 in all, mostly consulting fees. Lists University of Missouri Health Care as a hospital affiliation.
Overview
| NPI | 1154532885 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | May 24, 2007 |
| Last updated in NPPES | Sep 20, 2023 |
| Certified by provider | Sep 20, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | 2023037002 | MO |
| Internal Medicine | 207R00000X | 203059 | LA |
| Internal Medicine | 207R00000X | MD.203059 | LA |
| Internal Medicine, Hematology & Oncology | 207RH0003X | 56629 | TN |
| Internal Medicine | 207R00000X | 56629 | TN |
| Internal Medicine, Hematology & Oncology | 207RH0003X | 20059 | LA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 150 |
|---|---|
| Services billed | 641 across 11 procedure codes |
| Paid by Medicare | $38,497 |
Part D prescriptions in 2024
| Prescriptions (claims) | 189 · 205 30-day fills |
|---|---|
| Patients | 69 |
| Total drug cost | $493,499 |
| Generic share | 76% of claims |
Education and affiliations
| Graduation year | 2006 |
|---|---|
| Medicare specialty | Hematology/Oncology |
Hospital affiliation
- University of Missouri Health CareColumbia, MO
Industry payments (Open Payments)
- 2025$8,506 · 20 payments from 3 companies
- 2024$2,061 · 11 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,531 | 6 |
| Merck Sharp & Dohme LLC | $2,884 | 13 |
| Galvanize Therapeutics, Inc | $91.60 | 1 |
What the 2025 payments were for
- Consulting Fee$5,360 · 3 payments
- Travel and Lodging$2,514 · 6 payments
- Food and Beverage$632.33 · 11 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Hematology & Oncology providers in Columbia
- 1568886273
- 1457921264
- 1154302677
- 1922404367
- 1407843022
- 1477508786
- 1942243050
- 1851886196
- 1760429492
- 1154323376
- 1245568633
- 1952657462
All Internal Medicine, Hematology & Oncology providers in Missouri →